Lexicon Pharmaceuticals LXRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$1.04M+93.3% | -$15.53M-21.6% | -$12.77M-493% | $3.25M+113% | -$25.3M+25.1% | ||
| $110K-6.8% | $118K-21.9% | $151K-14.2% | $176K0.0% | $176K+40.8% | ||
| $3.08M+8.6% | $2.84M-17.7% | $3.44M+7.8% | $3.2M+5.0% | $3.04M+98.0% | ||
| -$14.73M+14.5% | -$17.23M+27.7% | -$23.83M— | —— | -$43.78M-104% | ||
| -$70.26M-1,555% | $4.83M-90.7% | $52.13M+237% | $15.48M-61.8% | $40.58M— | ||
| $5M+66.7% | $3M— | $0-100% | $45M— | $0— | ||
| $88.76M+3,132% | -$2.93M— | $0+100% | -$45M-7,767% | -$572K— | ||
| $3.76M+125% | -$15.33M-154% | $28.29M+326% | -$12.52M-232% | -$3.77M-112% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lexicon Pharmaceuticals generate?
- Lexicon Pharmaceuticals (LXRX) generated -$99.6M in operating cash flow over the trailing twelve months.
- Where does Lexicon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
